BridgeMD
Tests treatment safety and results for Atopic Dermatitis
Official title Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
ClinicalTrials.gov ID: NCT06756438
What this study is testing
- What it's testing
- Atopic eczema is a chronic inflammatory skin disease, mainly affecting children, characterized by itching and flare-ups. It results from genetic and environmental factors, leading to immunological and cutaneous abnormalities.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 12
You may be able to join if
- Specific
- Sex: female and/or male;
- Age: from 3 months up to 12 years old;
- Phototype: I to IV;
- 100% with atopic skin;
You likely can't join if
- Cutaneous pathology on the study zone other than atopic dermatitis;
- Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the how well it works of the study...
- Subject having undergone a surgery under general anesthesia within the previous month;
- Excessive exposure to sunlight or UV-rays within the previous month;
- Subject enrolled in another clinical trial during the study period (concerns the studied zones);
- people presenting oozing eczema lesions or any sign of infection on eczema lesions (e.g; pus).
See the full eligibility criteria
- Specific
- Sex: female and/or male;
- Age: from 3 months up to 12 years old;
- Phototype: I to IV;
- 100% with atopic skin;
- 100% with sensitive skin;
- Subject who had at least 3 eczema flares-up of atopic dermatitis during the last 6 months before start of the study, including the crisis observed on D-X.
- Subject presenting on the visit D-X a flare-up of eczema for which the dermatologist prescribed treatment with topical corticosteroids treatment;
- people with SCORAD between 15 and 40 on D-X;
- Subject who do not require medical treatment anymore after using prescribed topical corticosteroids from D-X up to D0 and clinical signs of atopic dermatitis are resolved, to be defined on D0 visit (in case of...
- Healthy subject;
- Child whose at least one parent/legal guardian has given freely and expressly her/his informed consent;
- Child whose at least one parent/legal guardian is willing to adhere to the protocol and study procedures;
- Polish citizenship.
- Cutaneous pathology on the study zone other than atopic dermatitis;
- Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the how well it works of the study products, including anti-histaminic treatment (except prescribed...
- Subject having undergone a surgery under general anesthesia within the previous month;
- Excessive exposure to sunlight or UV-rays within the previous month;
- Subject enrolled in another clinical trial during the study period (concerns the studied zones);
- people presenting oozing eczema lesions or any sign of infection on eczema lesions (e.g; pus).
The study team makes the final eligibility decision.
Where it's taking place
- Gdansk, Poméranie, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 months to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gdansk, Poméranie, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.